Jiangsu Yuyue Medical Equipment & Supply (002223.SZ) Earnings Analysis

Jiangsu Yuyue Medical Equipment & Supply (002223.SZ) next reports earnings on 2026-08-22, consensus EPS 0.3794 CNY. Last quarter (2026-04-25) it missed with EPS 0.01571 CNY vs 0.2232 CNY est (-93%). It has beaten estimates in 0/5 recent quarters (0%). Trailing P/E 21.29.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002223.SZ next report earnings?

Next earnings date2026-08-22
Consensus EPS estimate0.3794 CNY
Revenue estimate2.24B

002223.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-250.01571 CNY0.2232 CNY-93%Miss
2026-04-240.4273 CNY0.4779 CNY-10.6%Miss
2025-10-240.2638 CNYn/an/an/a
2025-08-220.577 CNYn/an/an/a
2025-04-260.27 CNY0.3 CNY-10%Miss
2025-03-310.627 CNYn/an/an/a
2024-10-250.4106 CNY0.5 CNY-17.9%Miss
2024-08-230.4599 CNY0.6 CNY-23.4%Miss

Beat rate: 0/5 (0%) over reported quarters with consensus data.

002223.SZ valuation and analyst view

Trailing P/E21.29
Trailing EPS1.288 CNY
Price / book2.00
Dividend yield3.65%
Market cap27.94B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Jiangsu Yuyue Medical Equipment & Supply (002223.SZ)'s next earnings date?

Jiangsu Yuyue Medical Equipment & Supply is next scheduled to report on 2026-08-22, with a consensus EPS estimate of 0.3794 CNY and revenue estimate of 2.24B.

Did 002223.SZ beat earnings last quarter?

In its 2026-04-25 report, 002223.SZ posted EPS of 0.01571 CNY versus a 0.2232 CNY estimate — a miss of 93%.

What is 002223.SZ's earnings track record?

Over the last 5 reported quarters with consensus data, 002223.SZ beat estimates 0 times (0%).

What is 002223.SZ's current P/E ratio and EPS?

002223.SZ trades at a trailing P/E of 21.29 on trailing EPS of 1.2876770990686426 CNY.

What do analysts rate 002223.SZ?

002223.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.